Supplements and Featured Publications

Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL

Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL

A Personalized Approach to Disease Management in Psoriasis

A Personalized Approach to Disease Management in Psoriasis

From Evidence to Implementation: Clarifications Around the US Preventive Services Task Force Recommendations for HIV Pre-Exposure Prophylaxis

From Evidence to Implementation: Clarifications Around the US Preventive Services Task Force Recommendations for HIV Pre-Exposure Prophylaxis

Advancing the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema With Novel and Emerging Monoclonal Antibody Therapy

Advancing the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema With Novel and Emerging Monoclonal Antibody Therapy

Volume: 28
Issue: 3
Current Landscape of Treatment Options for Patients With Amyotrophic Lateral Sclerosis (ALS)

Current Landscape of Treatment Options for Patients With Amyotrophic Lateral Sclerosis (ALS)

A Review of a Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

A Review of a Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

Optimizing Outcomes in Multiple Sclerosis Through Individualized Treatment: Managed Care Considerations

Optimizing Outcomes in Multiple Sclerosis Through Individualized Treatment: Managed Care Considerations

2021 ASH Meeting cover

Exclusive Coverage of the 63rd American Society of Hematology Meeting & Exposition

Coverage of the 63rd American Society of Hematology Meeting & Exposition, which took place in a hybrid format.

Population Health Guide to the Evolution of Endpoints in Multiple Sclerosis

Population Health Guide to the Evolution of Endpoints in Multiple Sclerosis

The Underrecognized Burden of Atopic Dermatitis in the United States

The Underrecognized Burden of Atopic Dermatitis in the United States

Evaluating the Management of Cancer Immunotherapy (CIT): Roundtable Discussion

Evaluating the Management of Cancer Immunotherapy (CIT): Roundtable Discussion

Management of TRK Fusion Cancer: Evaluating Targeted Therapies

Management of TRK Fusion Cancer: Evaluating Targeted Therapies

Volume: 28
Issue: 2
Addressing the Individualized Needs in Hereditary Angioedema: Managed Care Strategies to Optimize Access to Care

Addressing the Individualized Needs in Hereditary Angioedema: Managed Care Strategies to Optimize Access to Care

Volume: 28
Issue: 1
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo